1. Home
  2. SIBN vs VALN Comparison

SIBN vs VALN Comparison

Compare SIBN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$12.92

Market Cap

576.4M

Sector

Health Care

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.43

Market Cap

875.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
VALN
Founded
2008
2012
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.4M
875.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SIBN
VALN
Price
$12.92
$6.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$24.13
$15.75
AVG Volume (30 Days)
517.2K
78.1K
Earning Date
05-04-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
41.33
N/A
EPS
N/A
N/A
Revenue
$67,301,000.00
N/A
Revenue This Year
$16.95
$4.00
Revenue Next Year
$14.93
$92.04
P/E Ratio
N/A
N/A
Revenue Growth
21.53
N/A
52 Week Low
$12.50
$5.43
52 Week High
$21.89
$12.25

Technical Indicators

Market Signals
Indicator
SIBN
VALN
Relative Strength Index (RSI) 35.92 25.90
Support Level N/A $5.69
Resistance Level $14.24 $6.73
Average True Range (ATR) 0.64 0.42
MACD 0.04 -0.57
Stochastic Oscillator 28.94 1.75

Price Performance

Historical Comparison
SIBN
VALN

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: